Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Page 10 of 10« First...678910

Will Sanofi’s Big Bet On Vaccines Pull It Out Of Its Diabetes Slump?

While reporting its first-quarter financial results yesterday, French drug giant Sanofi said that sales in its diabetes unit fell 3% year-over-year to 1.8 billion euros ($2 billion) and would likely lag for the rest of the year, due to competition in the U.S. The vaccines unit also saw its sales decline—by nearly 5% in the first quarter to […]

Read More »

Researchers Closer To Being Able To Change Blood Types

“We produced a mutant enzyme that is very efficient at cutting off the sugars in A and B blood, and is much more proficient at removing the subtypes of the A-antigen that the parent enzyme struggles with,” said David Kwan, the lead author of the study and a postdoctoral fellow in the Department of Chemistry. […]

Read More »

Worse survival after lung cancer surgery for residents of poor neighborhoods

(Reuters Health) – Residents of low-income neighborhoods with few high school graduates may be more likely to die after lung cancer surgery than more affluent patients, a U.S. study finds.   Researchers reviewed records for more than 200,000 patients who had lung cancer surgery from 2003 to 2011. They found that while factors such as […]

Read More »

New Study Examines Success Lessons of Sovaldi’s and Harvoni’s Blockbuster Launches

CHAPEL HILL, N.C., May 1, 2015 /PRNewswire/ — The breakthrough hepatitis C treatment, Sovaldi faced backlash from payers for its high price but manufacturer Gilead Sciences overcame initial market resistance through its patient support programs, strategic worldwide pricing, and effective public relations campaigns. Sovaldi’s high cure rate, short dosing period, and promise of less severe […]

Read More »

AHF Supports Development of Implant to Deliver HIV Drugs

LOS ANGELES–(BUSINESS WIRE)–Today AIDS Healthcare Foundation President Michael Weinstein issued the following statement on findings recently published in the Antimicrobial Agents and Chemotherapy report that scientists from the Oak Crest Institute of Science have created the first subdermal implant that delivers antiretroviral drugs for up to 40 days to prevent or treat HIV: “Numerous medical […]

Read More »

Less sports training tied to groin injury

(Reuters Health) – Groin injuries are common in sports requiring quick direction changes, acceleration and deceleration – and they’re even more common when athletes have less sport-specific training or weaker inner thigh muscles, researchers say.   Groin injuries are common in soccer, ice hockey, rugby, Australian rules football, Gaelic football and cricket, lead author Dr. […]

Read More »

The World Is Not Prepared For Terrifying Superbugs

It’s more than resistant bacterial superbugs that should scare us. Only a few months after the Wellcome Trust’s dire report on growing antibiotic resistance and the looming “post-antibiotic era,” a new report stresses that it is not just bacteria we need to worry about. Viruses and parasites are showing growing resistance to antimicrobials as well, […]

Read More »

Sanofi Delivers Q1 2015 Business EPS Growth of 2.6% at CER and 12.8% on a Reported Basis

  Source: PR Newswire Health

Read More »

Five-Year Follow-Up Study Further Supports Effectiveness and Safety of the Essure® Procedure as a Non-Surgical, Non-Hormonal Option for Permanent Contraception

WHIPPANY, N.J., May 1, 2015 /PRNewswire/ — Bayer HealthCare announced today that a study published online this week in The Journal of Minimally Invasive Gynecology reinforces findings from previous clinical studies that support the effectiveness and safety of the Essure® inserts and procedure for hysteroscopic sterilization, or permanent birth control. The prospective five-year follow-up study followed […]

Read More »

Mallinckrodt Pharmaceuticals Becomes First-Ever National Sponsor of the Lupus Foundation of America’s Walk to End Lupus Now

WASHINGTON, DC–(Marketwired – May 01, 2015) – Mallinckrodt Pharmaceuticals (NYSE: MNK) will join the Lupus Foundation of America in its efforts to end the cruel mystery of lupus by sponsoring its signature program, Walk to End Lupus Now™. Walk events take place in more than 60 cities across the country, making it the nation’s largest lupus […]

Read More »

Vernalis and Tris Pharma receive FDA approval of NDA for Tuzistra XR

MONMOUTH JUNCTION, N.J., May 1, 2015 /PRNewswire/ — Vernalis plc and Tris Pharma Inc. today announce that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Tuzistra XR (codeine polistirex and chlorpheniramine polistirex) extended-release oral suspension, CIII (DEA Schedule III).  Tuzistra XR is an extended-release oral suspension combination of […]

Read More »

Page 10 of 10« First...678910

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

June 2018 Focus: Biotech, Payer Access, DTC and more!


Ad Right Bottom

Main Navigation